Effects of neurokinin-1 and 3-receptor antagonists on the defensive behavior induced by electrical stimulation of the dorsal periaqueductal gray

Neuroscience

Volumn 201, Issue , 2012, Pages 134-145

  Broiz, A C ^a   Bassi, G S ^a   De Souza Silva, M A ^b   Brandao M L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Contextual fear conditioning; Dorsal periaqueductal gray; NK 1 and NK 3 receptors; SB 222200; Spantide; Unconditioned fear

Indexed keywords

N (ALPHA ETHYLBENZYL) 3 METHYL 2 PHENYL 4 QUINOLINECARBOXAMIDE; NEUROKININ 1 RECEPTOR; NEUROKININ 3 RECEPTOR; SPANTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVERSION; CONDITIONING; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; ELECTROSTIMULATION; FEAR; FREEZING; HISTOLOGY; MALE; MOTOR DYSFUNCTION; NONHUMAN; OPEN FIELD BEHAVIOR; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RAT;

ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; BIOPHYSICS; CONDITIONING, CLASSICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ESCAPE REACTION; EXPLORATORY BEHAVIOR; FREEZING REACTION, CATALEPTIC; MALE; MICROINJECTIONS; MOTOR ACTIVITY; PERIAQUEDUCTAL GRAY; QUINOLINES; RATS; RATS, WISTAR; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-3; SUBSTANCE P;

EID: 84855544353     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.11.031     Document Type: Article

References (85)

1. Aguiar M.S., Brandão M.L. Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behaviour of rats in the plus-maze test. Physiol Behav 1996, 60:1183-1186.
2. Aguiar M.S., Brandão M.L. Conditioned place aversion produced by microinjections of substance P into the periaqueductal gray of rats. Behav Pharmacol 1994, 5:369-373.
3. Alvaro G., Di Fabio R. Neurokinin 1 receptor antagonists-current prospects. Curr Opin Drug Discov Devel 2007, 10:613-621.
4. Barbaresi P. Immunocytochemical localization of substance P receptor in rat periaqueductal gray matter: a light and electron microscopic study. J Comp Neurol 1998, 398:473-490.
5. Bassi G.S., Broiz A.C., Gomez M.Z., Brandão M.L. Evidence for mediation of nociception by injection of the NK-3 receptor agonist, senktide, into the dorsal periaqueductal gray of rats. Psychopharmacology (Berl) 2009, 2041:13-24.
6. Bassi G.S., Nobre M.J., Carvalho M.C., Brandão M.L. Substance P injected into the dorsal periaqueductal gray causes anxiogenic effects similar to the long-term isolation as assessed by ultrasound vocalizations measurements. Behav Brain Res 2007, 1822:301-330.
7. Bassi G.S., Nobre M.J., De Araújo J.E., Brandão M.L. Anxiogenic effects of activation of NK-1 receptors of the dorsal periaqueductal gray as assessed by the elevated plus-maze, ultrasound vocalizations and tail-flick tests. Neuropeptides 2007, 41:365-374.
8. Bhatt S., Siegel A. Potentiating role of interleukin 2 (IL-2) receptors in the midbrain periaqueductal gray (PAG) upon defensive rage behavior in the cat: role of neurokinin NK(1) receptors. Behav Brain Res 2006, 167:251-260.
9. Bhatt S., Gregg T.R., Siegel A. NK1 receptors in the medial hypothalamus potentiate defensive rage behavior elicited from the midbrain periaqueductal gray of the cat. Brain Res 2003, 966:54-64.
10. Blanchard D.C., Blanchard R.J. Innate and conditioned reactions to threat in rats with amygdaloid lesions. J Comp Physiol Psychol 1972, 81:281-290.
11. Blanchard D.C., Blanchard R.J., Rodgers R.J. Pharmacological and neural control of antipredator defense in the rat. Aggress Behav 1990, 16:165-175.
12. Blanchard R.J., Blanchard D.C. Crouching as an index of fear. J Comp Physiol Psychol 1969, 67:370-375.
13. Bondy B., Baghai T.C., Minov C., Schüle C., Schwarz M.J., Zwanzger P., Rupprecht R., Möller H.J. Substance P serum levels are increased in major depression, preliminary results. Biol Psychiatry 2003, 536:538-542.
14. Borelli K.G., Nobre M.J., Brandão M.L. Effects of acute and chronic fluoxetine and diazepam on freezing behavior induced by electrical stimulation of dorsolateral and lateral columns of the periaqueductal gray matter. Pharmacol Biochem Behav 2004, 77:557-566.
15. Borelli K.G., Ferreira-Netto C., Coimbra N.C., Brandão M.L. Fos-like immunoreactivity in the brain associated with freezing or escape induced by inhibition of either glutamic acid decarboxylase or GABAA receptors in the dorsal periaqueductal gray. Brain Res 2005, 105:100-111.
16. Brandão M.L., de Aguiar J.C., Graeff F.G. GABA mediation of the anti-aversive action of minor tranquilizers. Pharmacol Biochem Behav 1982, 16:397-402.
17. Brandão M.L., Anseloni V.Z., Pandóssio J.E., De Araújo J.E., Castilho V.M. Neurochemical mechanisms of the defensive behavior in the dorsal midbrain. Neurosci Biobehav Rev 1999, 23:863-875.
18. Brandão M.L., Vianna D.M., Masson S., Santos J. Organização neural de diferentes tipos de medo e suas implicações na ansiedade. Arq Bras Psiquiat 2003, 252:36-41.
19. Brandão M.L., Zanoveli J.M., Ruiz-Martinez R.C., Oliveira L.C., Landeira-Fernandez J. Different patterns of freezing behavior organized in the periaqueductal gray of rats, association with different types of anxiety. Behav Brain Res 2008, 89:76-84.
20. Broiz A.C., Oliveira L.C., Brandão M.L. Regulation of conditioned and unconditioned fear in rats by 5-HT1A receptors in the dorsal periaqueductal gray. Pharmacol Biochem Behav 2008, 89:76-84.
21. Coimbra N.C., Brandão M.L. GABAergic nigro-collicular pathways modulate the defensive behaviour elicited by midbrain tectum stimulation. Behav Brain Res 1993, 59:131-139.
22. Commons K.G. Neuronal pathways linking substance P to drug addiction and stress. Brain Res 2010, 1314:175-182.
23. Commons K.G., Valentino R.J. Cellular basis for the effects of substance P in the periaqueductal gray and dorsal raphe nucleus. J Comp Neurol 2002, 447:82-97.
24. Chahl L.A. Tachykinins and neuropsychiatric disorders. Curr Drug Targets 2006, 78:993-1003.
25. Dableh L.J., Yashpal K., Rochford J., Henry J.L. Antidepressant-like effects of neurokinin receptor antagonists in the forced swim test in the rat. Eur J Pharmacol 2005, 507:99-105.
26. De Araújo J.E., Brandão M.L., Huston J.P. Anxiogenic effects of substance P and its 7-11 C terminal, but not the 1-7 N terminal injected into the dorsal periaqueductal gray. Peptides 1999, 20:1437-1444.
27. De Araújo J.E., Huston J.P., Brandão M.L. Aversive effects of the C-fragment of substance P in the dorsal periaqueductal gray matter. Exp Brain Res 1998, 123:84-89.
28. De Araújo J.E., Huston J.P., Brandão M.L. Opposite effects of substance P fragments C anxiogenic and N anxiolytic injected into dorsal periaqueductal gray. Eur J Pharmacol 2001, 432:43-51.
29. De Araújo J.E., Huston J.P., Brandão M.L. Place aversion induced by microinjections of C-fragment of substance P into the dorsal periaqueductal gray of rats is mediated by tachykinin NK1 receptors. Peptides 2001, 22:1447-1452.
30. De Felipe C., Herrero J.F., O'Brien J.A., Palmer J.A., Doyle C.A., Smith A.J., Laird J.M., Belmonte C., Cervero F., Hunt S.P. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 1998, 392:394-397.
31. Deakin J.F.W., Graeff F.G. 5-HT and mechanisms of defence. J Psychopharmacol 1991, 5:305-315.
32. Drew G.M., Mitchell V.A., Vaughan C.W. Postsynaptic actions of substance P on rat periaqueductal grey neurons in vitro. Neuropharmacology 2005, 49:587-595.
33. Duarte F.S., Testolin R., De Lima T.C. Further evidence on the anxiogenic-like effect of substance P evaluated in the elevated plus-maze in rats. Behav Brain Res 2004, 154:501-510.
34. Ebner K., Sartori S.B., Singewald N. Tachykinin receptors as therapeutic targets in stress-related disorders. Curr Pharm Des 2009, 15:1647-1674.
35. Ferreira-Netto C., Borelli K.G., Brandão M.L. Neural segregation of Fos-protein distribution in the brain following freezing and escape behaviors induced by injections of either glutamate or NMDA into the dorsal periaqueductal gray of rats. Brain Res 2005, 1031:151-163.
36. Ferreira-Netto C., Borelli K.G., Brandão M.L. Distinct Fos expression in the brain following freezing behavior elicited by stimulation with NMDA of the ventral or dorsal inferior colliculus. Exp Neurol 2007, 204:693-704.
37. Graeff F.G. Brain defense systems and anxiety. Handbook of anxiety 1990, Vol. 3:307-354. Elsevier Science Publishers, New York. M. Roth, G.D. Burrow, R. Noyes (Eds.).
38. Graeff F.G. On serotonin and experimental anxiety. Psychopharmacology (Berl) 2002, 163:467-476.
39. Graeff F.G. Serotonin, the periaqueductal gray and panic. Neurosci Biobehav Rev 2004, 28:239-259.
40. Graeff F.G., Brandão M.L., Audi E.A., Schütz M.T. Modulation of the brain aversive system by GABAergic and serotonergic mechanisms. Behav Brain Res 1986, 21:65-72.
41. Gray J.A., McNaughton N. The neuropsychology of anxiety 2000, Oxford University Press, Oxford. 2nd ed.
42. Gregg T.R., Siegel A. Differential effects of NK1 receptors in the midbrain periaqueductal gray upon defensive rage and predatory attack in the cat. Brain Res 2003, 994:55-66.
43. Hasenohrl R.U., Souza-Silva M.A., Nikolaus S., Tomaz C., Brandao M.L., Schwarting R.K., Huston J.P. Substance P and its role in neural mechanisms governing learning, anxiety and functional recovery. Neuropeptides 2000, 34:272-280.
44. Hietala J., Nyman M.J., Eskola O., Laakso A., Grönroos T., Oikonen V., Bergman J., Haaparanta M., Forsback S., Marjamäki P., Lehikoinen P., Goldberg M., Burns D., Hamill T., Eng W.S., Coimbra A., Hargreaves R., Solin O. Visualization and quantification of neurokinin-1 (NK1) receptors in the human brain. Mol Imaging Biol 2005, 7:262-272.
45. Hokfelt T., Bartfai T., Bloom F. Neuropeptides, opportunities for drug discovery. Lancet Neurol 2003, 28:463-472.
46. Huston J.P., Hasenohrl R.U. The role of neuropeptides in learning: focus on the neurokinin substance P. Behav Brain Res 1995, 66:117-127.
47. Janecka A., Poels J., Fichna J., Studzian K., Vanden Broeck J. Comparison of antagonist activity of spantide family at human neurokinin receptors measured by aequorin luminescence-based functional calcium assay. Regul Pept 2005, 131:23-28.
48. Jenkinson K.M., Mann P.T., Southwell B.R., Furness J.B. Independent endocytosis of the NK1 and NK3 tachykinin receptors in neurons of the rat myenteric plexus. Neuroscience 2000, 100:191-199.
49. Johnson P.L., Shekhar A. Panic-prone state induced in rats with GABA dysfunction in the dorsomedial hypothalamus is mediated by NMDA receptors. J Neurosci 2006, 28:1015-1022.
50. Kramer M.S., Cutler N., Feighner J., Shrivastava R., Carman J., Sramek J.J., Reines S.A., Liu G., Snavely D., Wyatt-Knowles E., Hale J.J., Mills S.G., MacCoss M., Swain C.J., Harrison T., Hill R.G., Hefti F., Scolnick E.M., Cascieri M.A., Chicchi G.G., Sadowski S., Williams A.R., Hewson L., Smith D., Carlson E.J., Hargreaves R.J., Rupniak N.M. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 1998, 281:1640-1645.
51. Langlois X., Wintmolders C., te Riele P., Leysen J.E., Jurzak M. Detailed distribution of neurokinin 3 receptors in the rat, guinea pig and gerbil brain, a comparative autoradiographic study. Neuropharmacology 2001, 40:242-253.
52. Li Y.Q., Jia H.G., Rao Z.R., Shi J.W. Serotonin-, substance P- or leucine-enkephalin-containing neurons in the midbrain periaqueductal gray and nucleus raphe dorsalis send projection fibers to the central amygdaloid nucleus in the rat. Neurosci Lett 1990, 120:124-127.
53. Lim L.W., Blokland A., Visser-Vandewalle V., Vlamings R., Sesia T., Steinbusch H., Schruers K., Griez E., Temel Y. High-frequency stimulation of the dorsolateral periaqueductal gray and ventromedial hypothalamus fails to inhibit panic-like behaviour. Behav Brain Res 2008, 193:197-203.
54. Maeno H., Kiyama H., Tohyama M. Distribution of the substance P receptor (NK-1 receptor) in the central nervous system. Brain Res Mol Brain Res 1993, 18:43-58.
55. Maggi C.A. The mammalian tachykinin receptors. Gen Pharmacol 1995, 26:911-944.
56. Maisonnette S.S., Kawasaki M.C., Coimbra N.C., Brandão M.L. Effects of lesions of amygdaloid nuclei and substantia nigra on aversive responses induced by electrical stimulation of the inferior colliculus. Brain Res Bull 1996, 40:93-98.
57. Mantyh P.W. Neurobiology of substance P and the NK1 receptor. J Clin Psychiatry 2002, 63(Suppl 11):6-10.
58. Massi M., Panocka I., De Caro G. The psychopharmacology of tachykinin NK-3 receptors in laboratory animals. Peptides 2000, 21:1597-1609.
59. McLean S. Do substance P and the NK1 receptor have a role in depression and anxiety?. Curr Pharm Des 2005, 1112:1529-1547.
60. Meltzer H., Prus A. NK3 receptor antagonists for the treatment of schizophrenia. Drug Discov Today Ther Strat 2006, 34:555-560.
61. Mongeau R., Marsden C.A., De Oca B.M., Fanselow M.S. Differential effects of neurokinin-1 receptor activation in subregions of the periaqueductal gray matter on conditional and unconditional fear behaviors in rats. Behav Neurosci 1998, 1125:1125-1135.
62. Nagano M., Saitow F., Haneda E., Konishi S., Hayashi M., Suzuki H. Distribution and pharmacological characterization of primate NK-1 and NK-3 tachykinin receptors in the central nervous system of the rhesus monkey. Br J Pharmacol 2006, 147:316-323.
63. Oliveira L.C., Broiz A.C., Macedo C.E., Landeira-Fernandez J., Brandão M.L. 5-HT2 receptor mechanisms of the dorsal periaqueductal gray in the conditioned and unconditioned fear in rats. Psychopharmacology (Berl) 2007, 191:253-262.
64. Oliveira L.C., Nobre M.J., Brandão M.L., Landeira-Fernandez J. Role of amygdala in conditioned and unconditioned fear generated in the periaqueductal gray. Neuroreport 2004, 15:2281-2285.
65. Papaioannou V.E., Fox J.G. Efficacy of tribromoethanol anesthesia in mice. Lab Anim Sci 1993, 43:189-192.
66. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1997, Academic Press, San Diego, CA.
67. Pennefather J.N., Lecci A., Candenas M.L., Patak E., Pinto F.M., Maggi C.A. Tachykinins and tachykinin receptors, a growing family. Life Sci 2004, 7412:1445-1463.
68. Quartara L., Altamura M. Tackykinin receptors antagonists: from research to clinic. Curr Drug Targets 2006, 7:975-992.
69. Ranga K., Krishnan R. Clinical experience with substance P receptor NK1 antagonists in depression. J Clin Psychiatry 2002, 6311:25-29.
70. Regoli D. Pharmacological receptors for SP and neurokinins. Life Sci 1997, 40:109-117.
71. Regoli D., Boudon A., Fauchere J.L. Receptors and antagonists for substance P and related peptides. Pharmacol Rev 1994, 464:551-599.
72. Reiman E.M., Raichle M.E., Robins E. Neuroanatomical correlates of a lactate-induced anxiety attack. Arch Gen Psychiatry 1989, 46:493-500.
73. Ribeiro S.J., Teixeira R.M., Calixto J.B., De Lima T.C.M. Tachykinin NK3 receptor involvement in anxiety. Neuropeptides 1999, 332:181-188.
74. Rigby M., O'Donnell R., Rupniak N.M. Species differences in tachykinin receptor distribution: further evidence that the substance P (NK1) receptor predominates in human brain. J Comp Neurol 2005, 490:335-353.
75. Martinez R.C., de Oliveira A.R., Brandão M.L. Conditioned and unconditioned fear organized in the periaqueductal gray are differentially sensitive to injections of muscimol into amygdaloid nuclei. Neurobiol Learn Mem 2006, 85:58-65.
76. Santarelli L., Gobbi G., Debs P.C., Sibille E.T., Blier P., Hen R., Heath M.J. Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc Natl Acad Sci U S A 2001, 98:1912-1917.
77. Santos J.M., Gárgaro A.C., Oliveira A.R., Masson S., Brandão M.L. Pharmacological dissociation of moderate and high contextual fear as assessed by freezing behavior and fear-potentiated startle. Eur Neuropsychopharmacol 2005, 15:239-246.
78. Schäble S., Topic B., Buddenberg T., Petri D., Huston J.P., de Souza Silva M.A. Neurokinin3-R agonism in aged rats has anxiolytic-antidepressant-, and promnestic-like effects and stimulates ACh release in frontal cortex, amygdala and hippocampus. Eur Neuropsychopharmacol 2011, 21(6):484-494.
79. Severini C., Improta G., Falconieri-Erspamer G., Salvadori S., Erspamer V. The tachykinin peptide family. Pharmacol Rev 2002, 542:285-322.
80. Teixeira R.M., Santos A.R., Ribeiro S.J., Calixto J.B., Rae G.A., De Lima T.C. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice. Eur J Pharmacol 1996, 311:7-14.
81. Vianna D.M.L., Landeira-Fernandez J., Brandão M.L. Dorsolateral and ventral regions of the periaqueductal gray matter are involved in distinct types of fear. Neurosci Biobehav Rev 2001, 25:711-719.
82. Vianna D.M.L., Landeira-Fernandez J., Graeff F.G., Brandão M.L. Lesion of the ventral periaqueductal gray reduces conditioned fear but does not change freezing induced by stimulation of the dorsal periaqueductal gray. Learn Mem 2001, 8:164-169.
83. Yip J., Chahl L.A. Localization of NK1 and NK3 receptors in guinea-pig brain. Regul Peptides 2001, 98:55-62.
84. Zanoveli J.M., Pobbe R.L., De Bortoli V.C., Carvalho M.C., Brandão M.L., Zangrossi H. Facilitation of 5-HT1A-mediated neurotransmission in dorsal periaqueductal grey matter accounts for the panicolytic-like effect of chronic fluoxetine. Int J Neuropsychopharmacol 2010, 13:1079-1088.
85. Zlomuzica A., Dere E., Huston J.P., de Souza Silva M.A. NK(3) receptor agonism promotes episodic-like memory in mice. Neurobiol Learn Mem 2008, 90:420-425.